| Financial Year |
March 31 2023 |
| Monetary Funds |
249,273,256.65 |
| Held-for-trading Financial Assets |
2,090,726.20 |
| Notes Receivable |
-- |
| Accounts Receivable |
740,655,283.50 |
| Advances to Suppliers |
269,076,868.31 |
| Other Receivables |
114,144,451.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
529,278,030.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,883,987.92 |
| Total Current Assets |
3,197,695,606.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
902,812,488.69 |
| Investment Properties |
15,611,553.08 |
| Fixed Assetes |
886,760,986.47 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
911,155,495.65 |
| R&D expenses |
-- |
| Goodwill |
2,473,612.26 |
| Long-Term Deferred and Prepaid Expenses |
44,845.92 |
| Deferred Income Tax Assets |
610,801,474.48 |
| Other Non-Current Assets |
3,342,851,843.15 |
| Sub-Total of Non-Current Assets |
6,821,485,334.33 |
| Total Assets |
10,019,180,941.03 |
| Short-Term Loans |
1,707,748,311.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,697,600.00 |
| Accounts Received In Advance |
1,815,348,839.79 |
| Employee Compensation Payable |
20,872,752.65 |
| Taxes Payable |
111,048,293.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,246,422,882.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
324,593,862.83 |
| Other Current Liabilities |
15,922,365.91 |
| Sub-Total of Current Liabilities |
5,625,398,801.89 |
| Long-term Loans |
3,092,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,609,759.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
80,870,942.38 |
| Deferred Income Tax Liabilities |
230,671.77 |
| Other Non-Current Liabilities |
162,524,917.56 |
| Sub-Total of Non-Current Liabilities |
3,476,085,174.21 |
| Total Liabilities |
9,101,483,976.10 |
| Paid-In Capital(Or Share Stock) |
1,180,800,000.00 |
| Capital Surplus |
952,291,617.26 |
| Surplus Reserve |
113,144,919.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,421,345,979.52 |
| Minority Stockholder's Interest |
158,809,719.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
758,887,245.67 |
| Owner's Equity（Stockholder's Equity） |
917,696,964.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,019,180,941.03 |
